Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the blockbuster weight-loss market.
Source: https://www.reuters.com/business/healthcare-pharmaceuticals/…
The U.S. cannabis industry is approaching a potentially important inflection point before 2026. Federal policy discussions are continuing to gain momentum behind the scenes.
Buying a stock is easy, but buying the right stock without a good strategy is incredibly hard. Here are five top-performing stocks to buy now or put on a watchlist.
The 8 “big and rich” tech stocks ARE the stock market (37% of the S&P 500), but indexation reduces long-term stock-picking value. My technical analysis of these is thus for shorter-term, tactical trading, viewing the giants as too overvalued for long-term holding.
